Company Filing History:
1 out of 1,244 
1 out of 345 
1 out of 1 Years Active: 2017
Title: Yu-Chul Chung: Innovator in Antiviral Agents
Introduction
Yu-Chul Chung is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of antiviral agents, particularly those targeting animal viruses. His innovative work has the potential to impact both veterinary medicine and animal health.
Latest Patents
Yu-Chul Chung holds a patent for an antiviral agent against animal viruses. This antiviral agent comprises a protein or a nucleic acid sequence encoding the protein as an active ingredient. The protein exhibits binding and degrading abilities to foreign nucleic acid chains that invade animal cells, while demonstrating no cytotoxicity to the animal cells themselves. The invention also includes an antiviral animal cell containing the protein or the nucleic acid sequence. This antiviral agent and animal cell are advantageous as they selectively degrade foreign nucleic acid chains without harming the animal cells, thus preventing cell death.
Career Highlights
Throughout his career, Yu-Chul Chung has been associated with notable institutions such as Sungkyunkwan University and Ajou University Industry-Academic Cooperation Foundation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Yu-Chul Chung has collaborated with esteemed colleagues, including Suk-Chan Lee and Yong-Sung Kim. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of antiviral research.
Conclusion
Yu-Chul Chung's contributions to antiviral agents represent a significant advancement in the fight against animal viruses. His innovative approach and dedication to research continue to pave the way for future developments in this critical area of science.